USD 10.96
(-8.21%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2.06 Million USD | -24.05% |
2022 | 2.71 Million USD | -23.52% |
2021 | 3.55 Million USD | 115.98% |
2020 | 1.64 Million USD | 4.18% |
2019 | 1.58 Million USD | -53.62% |
2018 | 3.4 Million USD | 25.49% |
2017 | 2.71 Million USD | 36.3% |
2016 | 1.99 Million USD | 14.02% |
2015 | 1.74 Million USD | 63.42% |
2014 | 1.06 Million USD | 35.32% |
2013 | 790 Thousand USD | 128.32% |
2012 | 346 Thousand USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 7.76 Million USD | 147.4% |
2024 Q1 | 3.13 Million USD | 482.37% |
2023 Q3 | 434 Thousand USD | -12.32% |
2023 FY | 2.06 Million USD | -24.05% |
2023 Q2 | 495 Thousand USD | -17.09% |
2023 Q1 | 597 Thousand USD | -6.57% |
2023 Q4 | 539 Thousand USD | 24.19% |
2022 Q3 | 906 Thousand USD | 13.68% |
2022 Q1 | 378 Thousand USD | -82.07% |
2022 Q2 | 797 Thousand USD | 110.85% |
2022 Q4 | 639 Thousand USD | -29.47% |
2022 FY | 2.71 Million USD | -23.52% |
2021 FY | 3.55 Million USD | 115.98% |
2021 Q4 | 2.1 Million USD | 303.83% |
2021 Q3 | 522 Thousand USD | -2.61% |
2021 Q2 | 536 Thousand USD | 38.14% |
2021 Q1 | 388 Thousand USD | -23.47% |
2020 Q4 | 507 Thousand USD | 8.8% |
2020 Q3 | 466 Thousand USD | 22.96% |
2020 Q1 | 294 Thousand USD | -43.13% |
2020 Q2 | 379 Thousand USD | 28.91% |
2020 FY | 1.64 Million USD | 4.18% |
2019 Q2 | 412 Thousand USD | 52.59% |
2019 FY | 1.58 Million USD | -53.62% |
2019 Q4 | 517 Thousand USD | 36.05% |
2019 Q3 | 380 Thousand USD | -7.77% |
2019 Q1 | 270 Thousand USD | -73.61% |
2018 FY | 3.4 Million USD | 25.49% |
2018 Q2 | 858 Thousand USD | 22.22% |
2018 Q3 | 824 Thousand USD | -3.96% |
2018 Q4 | 1.02 Million USD | 24.15% |
2018 Q1 | 702 Thousand USD | -0.28% |
2017 Q4 | 704 Thousand USD | 2.92% |
2017 Q3 | 684 Thousand USD | 17.12% |
2017 Q2 | 584 Thousand USD | -21.4% |
2017 Q1 | 743 Thousand USD | 9.91% |
2017 FY | 2.71 Million USD | 36.3% |
2016 Q1 | 370 Thousand USD | -15.72% |
2016 Q3 | 435 Thousand USD | -14.87% |
2016 Q2 | 511 Thousand USD | 38.11% |
2016 FY | 1.99 Million USD | 14.02% |
2016 Q4 | 676 Thousand USD | 55.4% |
2015 FY | 1.74 Million USD | 63.42% |
2015 Q3 | 399 Thousand USD | -14.38% |
2015 Q1 | 444 Thousand USD | 52.58% |
2015 Q4 | 439 Thousand USD | 10.03% |
2015 Q2 | 466 Thousand USD | 4.95% |
2014 FY | 1.06 Million USD | 35.32% |
2014 Q2 | 251 Thousand USD | -19.03% |
2014 Q1 | 310 Thousand USD | -8.28% |
2014 Q4 | 291 Thousand USD | 34.1% |
2014 Q3 | 217 Thousand USD | -13.55% |
2013 Q2 | - USD | -100.0% |
2013 FY | 790 Thousand USD | 128.32% |
2013 Q4 | 338 Thousand USD | 369.44% |
2013 Q3 | 72 Thousand USD | 0.0% |
2013 Q1 | 381 Thousand USD | 90.5% |
2012 FY | 346 Thousand USD | 0.0% |
2012 Q4 | 200 Thousand USD | 412.82% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | 106 Thousand USD | 0.0% |
2012 Q3 | 39 Thousand USD | -63.21% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1998 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Accuray Incorporated | 446.55 Million USD | 99.538% |
Envoy Medical, Inc. | 316 Thousand USD | -553.481% |
Xylo Technologies Ltd. | 91.72 Million USD | 97.749% |